These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10700531)

  • 1. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers.
    Nicod N; Giusti V; Besse C; Tappy L
    Obes Res; 2003 May; 11(5):625-31. PubMed ID: 12740452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
    Pereira Arias AM; Bisschop PH; Ackermans MT; Endert E; Romijn JA; Sauerwein HP
    Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of colostrum feeding and glucocorticoid administration on insulin-dependent glucose metabolism in neonatal calves.
    Scheuer BH; Zbinden Y; Schneiter P; Tappy L; Blum JW; Hammon HM
    Domest Anim Endocrinol; 2006 Oct; 31(3):227-45. PubMed ID: 16360295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
    Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
    J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of hepatic glucagon resistance associated with hepatic steatosis: reversal effect of training.
    Charbonneau A; Couturier K; Gauthier MS; Lavoie JM
    Int J Sports Med; 2005; 26(6):432-41. PubMed ID: 16037884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of glucose homeostasis in humans with denervated livers.
    Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
    J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine-induced insulin resistance in man.
    Deibert DC; DeFronzo RA
    J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
    Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW
    J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
    Li L; Yang GY
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O; Vilstrup H
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose metabolism during exercise in man: the role of insulin in the regulation of glucose utilization.
    Lavoie C; Ducros F; Bourque J; Langelier H; Chiasson JL
    Can J Physiol Pharmacol; 1997 Jan; 75(1):36-43. PubMed ID: 9101063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
    Felig P; Wahren J; Hendler R
    J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin increases hepatic insulin extraction.
    O'Brien DW; Rajotte RV; Molnar GD; Toth K; Petersen TD
    Diabetes Res; 1988 Apr; 7(4):171-8. PubMed ID: 2900090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.